mcr-1 Gene Has No Effect on Colistin Resistance When It Coexists with Inactivated mgrB Gene in Klebsiella pneumoniae

Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease
Huichuan ZhangYunsong Yu

Abstract

The inactivated mgrB gene and the mcr-1 gene are important mechanisms of colistin resistance in Klebsiella pneumoniae and they are threats to the clinical use of colistin. In this study, mcr-1 gene was cloned into K. pneumoniae strains (XH209 and KP10) and their derived strains (XH209 M and KP10 M), which showed high-level resistance to colistin. The acquisition of the mcr-1 gene led to colistin resistance in XH209 and KP10, but the addition of mcr-1 gene did not cause change of colistin minimum inhibitory concentrations in the XH209 M and KP10 M. In addition, the impact of mcr-1 gene on growth rate showed strain specific in K. pneumoniae. In conclusion, the mcr-1 gene does not cause the same level of colistin resistance as the inactivated mgrB gene in K. pneumoniae. The mcr-1 gene has no effect on colisitin resistance when it coexists with inactivated mgrB gene in K. pneumoniae.

References

Mar 17, 2007·Annual Review of Biochemistry·Christian R H RaetzRussell E Bishop
Mar 12, 2011·The Journal of Antimicrobial Chemotherapy·Georgios MeletisDanai Sofianou
Jul 16, 2014·Antimicrobial Agents and Chemotherapy·Antonio CannatelliUNKNOWN COLGRIT Study Group
Sep 6, 2014·The Journal of Antimicrobial Chemotherapy·Laurent PoirelPatrice Nordmann
Dec 17, 2014·Frontiers in Microbiology·Abiola O OlaitanJean-Marc Rolain
Jan 9, 2015·Clinical Microbiology Reviews·Omar M El-Halfawy, Miguel A Valvano
Feb 24, 2015·Current Medical Research and Opinion·Abed Zahedi Bialvaei, Hossein Samadi Kafil
Nov 29, 2016·PLoS Pathogens·Rongsui GaoYoujun Feng
Apr 19, 2017·Emerging Infectious Diseases·Yvan CasparMax Maurin

❮ Previous
Next ❯

Datasets Mentioned

BETA
KY012274

Methods Mentioned

BETA
PCR

Software Mentioned

Basic Local Alignment Search Tool
R

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

The Lancet Infectious Diseases
Rong ZhangSheng Chen
The Lancet Infectious Diseases
Chanping ZhiJian-Hua Liu
The Lancet Infectious Diseases
Michael R MulveyRoberto G Melano
The Lancet Infectious Diseases
Etienne RuppéS Dusko Ehrlich
© 2022 Meta ULC. All rights reserved